--- title: News/Publications description: The latest updates on drug candidate KM-819 --- [![FAScinate-Logo](https://www.fascinatetherapeutics.com/hs-fs/hubfs/FAScinate-Logo.png?width=995&height=296&name=FAScinate-Logo.png "FAScinate-Logo")](http://fascinatetherapeutics.com) - [한국어 - 대한민국](https://www.fascinatetherapeutics.com/ko-kr/news) - [English](https://www.fascinatetherapeutics.com/news) 한국어 - 대한민국 Search - [About Us](https://www.fascinatetherapeutics.com/about-us) - [Product Overview](https://www.fascinatetherapeutics.com/product-overview) - [Partnerships](https://www.fascinatetherapeutics.com/partnerships) - [News/Publications](https://www.fascinatetherapeutics.com/news) # News/Publications ## The latest updates on drug candidate KM-819. [![footer-logo](https://www.fascinatetherapeutics.com/hs-fs/hubfs/footer-logo.png?width=996&height=297&name=footer-logo.png "footer-logo")](https://www.fascinatetherapeutics.com/) ##### Quick Links - [Product Overview](https://www.fascinatetherapeutics.com/product-overview) - [About Us](https://www.fascinatetherapeutics.com/about-us) - [Partnerships](https://www.fascinatetherapeutics.com/partnerships) - [News](https://www.fascinatetherapeutics.com/news) #### Contact Us FAScinate Therapeutics 4365 Executive Dr. Ste. 660 San Diego, CA 92121 [(858) 630-8540](tel:+18586308540) [contact@fascinatetherapeutics.com](mailto:contact@fascinatetherapeutics.com) © FAScinate Therapeutics 2026 | All rights reserved.